A Single Patient IND for PD-0325901
NCT02297802 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2014-11-26
Summary
The purpose of this study is to provide access for a single patient to PD-0325901 who was previously enrolled in a phase I clinical trial.
Conditions
- Prior Treatment With PD-0325901 With Ongoing Clinical Response
Interventions
- DRUG
-
PD-0325901
Sponsors & Collaborators
-
Sharp HealthCare
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2013-07-31
- Completion
- 2013-07-31
Countries
- United States
Study Locations
More Related Trials
-
Single Ascending Dose Study of TD-0714 in Healthy Subjects
NCT02639078 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses ofAZD2551
NCT00860353 ·Status: TERMINATED ·Phase: PHASE1
-
An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects
NCT02551549 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55375515 in Healthy Participants
NCT02623491 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Ascending Dose Study of CD101 IV in Healthy Subjects
NCT02516904 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety and Tolerability of JNJ-61178104 in Healthy Participants
NCT02758392 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8529 Single Ascending Dose Study
NCT00755378 ·Status: COMPLETED ·Phase: PHASE1
-
Study of NAV-240 in Healthy Volunteers
NCT06181786 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of SHR2285 in Healthy Subjects
NCT04829305 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics Study of ATH-1020
NCT05169671 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Participants
NCT02471859 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42847922 in Healthy Participants
NCT02230878 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Single Ascending Doses of PF-07258669 in Healthy Adult Participants
NCT04628793 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
NCT07219368 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-777991 in Healthy Subjects
NCT04798209 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults
NCT06815991 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-64232025 in Healthy Participants
NCT03550950 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of AZD4205 in Healthy Adult Subjects
NCT03728023 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Ascending Dose Study and Food Effect Study for AG181
NCT06286033 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects
NCT01739647 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RDX5791 in Healthy Volunteers
NCT02819687 ·Status: COMPLETED ·Phase: PHASE1
-
A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR206 in Healthy Volunteers
NCT03792308 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males
NCT02484729 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of S-1117
NCT06828393 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers
NCT01597947 ·Status: COMPLETED ·Phase: PHASE1